Alice M. Biggane

First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study

Siow Ming Lee, Christian Schulz, Kumar Prabhash et al. · The Lancet · 2023 · 142 citations

First-line Atezolizumab Monotherapy, Medicine, Pharmacology +8

Survey indicated that core outcome set development is increasingly including patients, being conducted internationally and using Delphi surveys

Alice M. Biggane, Lucy Brading, Philippe Ravaud et al. · Trials · 2018 · 64 citations · Full text

PPI in research: a reflection from early stage researchers

Alice M. Biggane, Maria Olsen, Paula Williamson · Research Involvement and Engagement · 2019 · 61 citations · Full text

Period poverty: The perceptions and experiences of impoverished women living in an inner-city area of Northwest England

Madeleine Boyers, Supriya Garikipati, Alice M. Biggane et al. · PLoS ONE · 2022 · 50 citations · Full text

Participating in core outcome set development via Delphi surveys: qualitative interviews provide pointers to inform guidance

Alice M. Biggane, Paula Williamson, Philippe Ravaud et al. · BMJ Open · 2019 · 40 citations · Full text